To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene WDR34TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
283 representative clones for gene WDR34 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_052844.3   .a 1 to 1818 1 to 1818 exact RefSeq,   1818/1818
(100 %)
0 diff
(100 %id)
BG685626 B-cells, primary B-cells from tonsils (cell line) .a 61 to 835 1 to 774   tiling clone,   774/786
(98 %)
11 diff
(98.7 %id)
CR605861 Neuroblastoma Cot 50-normalized .a 62 to 1785 1 to 1724 exact     1724/1724
(100 %)
0 diff
(100 %id)
BC011874 Brain, neuroblastoma .a 64 to 1818 1 to 1755 W60G tiling clone, available from MGC, AAA   1755/1755
(100 %)
5 diff
(99.8 %id)
CR618445 B cells (Ramos cell line) Cot 25-normalized .a 112 to 1785 1 to 1674 exact     1674/1674
(100 %)
0 diff
(100 %id)
BX342701   .a 112 to 943 1 to 827   fully sequenced,   827/827
(100 %)
8 diff
(99.1 %id)
BI259718 cervical carcinoma cell line, cervix .a 118 to 220 1 to 103       103/103
(100 %)
0 diff
(100 %id)
BM547073 brain, hippocampus .a 120 to 936 13 to 834       822/1102
(74 %)
29 diff
(97.4 %id)
CD557578 testis .a 123 to 927 1 to 815       815/893
(91 %)
21 diff
(97.7 %id)
BM918367 pooled pancreas and spleen .a 124 to 1038 1 to 925       922/1073
(85 %)
20 diff
(98.2 %id)
CR616487 fetal liver .a 127 to 1777 1 to 1651       1651/1651
(100 %)
0 diff
(100 %id)
BX444139 fetal liver, Liver .a 127 to 899 1 to 774   fully sequenced,   774/774
(100 %)
5 diff
(99.4 %id)
BE799196 lung, small cell carcinoma .a 127 to 939 4 to 815       812/1058
(76 %)
19 diff
(98.3 %id)
BI457076 epithelioid carcinoma cell line, Pancreas .a 127 to 846 1 to 720       720/723
(99 %)
7 diff
(99.1 %id)
BG037182 testis .a 130 to 835 1 to 701       703/819
(85 %)
23 diff
(97.2 %id)
BX463870 brain, fetal brain .a 136 to 1077 25 to 960       936/963
(97 %)
17 diff
(98.3 %id)
BI518898 leukocyte .a 138 to 969 1 to 827       827/827
(100 %)
10 diff
(98.8 %id)
BI909397 leukocyte .a 138 to 881 1 to 743       743/744
(99 %)
7 diff
(99.1 %id)
BI831212 brain, medulla .a 146 to 856 1 to 707       707/707
(100 %)
10 diff
(98.6 %id)
CR594160 T cells (Jurkat cell line) Cot10-normalized .a 147 to 1782 1 to 1636       1636/1636
(100 %)
0 diff
(100 %id)
CR604643 B cells (Ramos cell line) Cot 25-normalized .a 147 to 1785 1 to 1639       1639/1639
(100 %)
0 diff
(100 %id)
AL558177 T cells from T cell leukemia .a 147 to 1060 1 to 908       908/942
(96 %)
22 diff
(97.7 %id)
BX402784   .a 147 to 1203 1 to 1050       1050/1080
(97 %)
20 diff
(98.2 %id)
BX363816   .a 147 to 898 1 to 752   fully sequenced,   752/752
(100 %)
3 diff
(99.7 %id)
TI_57240504   .a 147 to 982 32 to 862       831/862
(96 %)
14 diff
(98.4 %id)
BG761728 melanotic melanoma, high MDR (cell line), skin .a 151 to 876 1 to 728       728/778
(93 %)
13 diff
(98.4 %id)
CR618791 B cells (Ramos cell line) Cot 25-normalized .a 152 to 1784 1 to 1633       1633/1633
(100 %)
0 diff
(100 %id)
BX364151   .a 152 to 968 1 to 817   fully sequenced,   817/817
(100 %)
10 diff
(98.8 %id)
BI760954 pooled colon, kidney, stomach .a 152 to 979 1 to 827       827/827
(100 %)
14 diff
(98.4 %id)
BI913465 brain .a 152 to 982 1 to 826       826/826
(100 %)
10 diff
(98.8 %id)
CR611062 T cells (Jurkat cell line) Cot10-normalized .a 158 to 1776 1 to 1619       1619/1619
(100 %)
0 diff
(100 %id)
CR613767 HeLa cells Cot 25-normalized .a 158 to 1787 1 to 1630       1630/1630
(100 %)
0 diff
(100 %id)
CX164442 human embryonic stem cells differentiated toan early endodermal cell type .a 160 to 912 1 to 753       753/753
(100 %)
1 diff
(99.9 %id)
CR591802 B cells (Ramos cell line) .a 162 to 1808 1 to 1647       1647/1647
(100 %)
0 diff
(100 %id)
CR601726 Placenta Cot 25-normalized .a 162 to 1822 1 to 1661   tiling clone,   1661/1661
(100 %)
0 diff
(100 %id)
CR614951 Neuroblastoma Cot 10-normalized .a 162 to 1794 1 to 1633       1633/1633
(100 %)
0 diff
(100 %id)
CR618259 Neuroblastoma Cot 50-normalized .a 162 to 1796 1 to 1635       1635/1635
(100 %)
0 diff
(100 %id)
CX165534 human embryonic stem cells differentiated toan early endodermal cell type .a 162 to 975 1 to 814       814/814
(100 %)
1 diff
(99.9 %id)
CR615609 HeLa cells Cot 25-normalized .a 163 to 1804 1 to 1642       1642/1642
(100 %)
0 diff
(100 %id)
BX363344   .a 163 to 999 1 to 835   fully sequenced,   835/835
(100 %)
3 diff
(99.7 %id)
AL520185 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 164 to 996 2 to 827   fully sequenced,   826/827
(99 %)
8 diff
(99.1 %id)
BX460741 brain, fetal brain .a 164 to 1063 2 to 901       900/904
(99 %)
7 diff
(99.3 %id)
AL559946 B cells (Ramos cell line), B cells from Burkitt lymphoma .a 164 to 898 2 to 736   fully sequenced,   735/736
(99 %)
8 diff
(99.0 %id)
BX336310 Placenta Cot 25-normalized .a 164 to 1004 2 to 842       841/842
(99 %)
9 diff
(99.0 %id)
BX343834 Placenta Cot 25-normalized .a 164 to 1221 2 to 1043       1042/1049
(99 %)
35 diff
(96.7 %id)
BM927711 hepatocellular carcinoma, cell line, Liver .a 164 to 898 1 to 749       749/1109
(67 %)
13 diff
(98.9 %id)
BQ942756 large cell carcinoma, lung .a 164 to 935 1 to 784       784/956
(82 %)
19 diff
(98.1 %id)
BX382530 Placenta Cot 25-normalized .a 165 to 1192 1 to 1022       1022/1045
(97 %)
29 diff
(97.3 %id)
BI821842 pooled brain, lung, testis .a 165 to 935 1 to 777       777/777
(100 %)
13 diff
(98.4 %id)
BC001614.
matches multiple genes
lung, Lung, small cell carcinoma, small cell carcinoma .a 166 to 1818 1 to 1653   available from MGC, AAA also hits gene VPS72andTMOD4 1653/1653
(100 %)
5 diff
(99.7 %id)
BU192403 large cell carcinoma, lung .a 166 to 935 1 to 780       780/948
(82 %)
27 diff
(97.2 %id)
BG822157 adenocarcinoma cell line, colon .a 168 to 897 1 to 731       731/731
(100 %)
5 diff
(99.4 %id)
BU543966 carcinoma, cell line, Prostate .a 168 to 936 1 to 768       768/932
(82 %)
8 diff
(99.2 %id)
BG481959 choriocarcinoma, placenta .a 169 to 993 1 to 821       821/824
(99 %)
16 diff
(98.1 %id)
BG818493 anaplastic oligodendroglioma with 1p/19qloss, brain .a 169 to 882 1 to 712       712/712
(100 %)
11 diff
(98.5 %id)
BI334893 cervical carcinoma cell line, cervix .a 169 to 220 1 to 52       52/52
(100 %)
0 diff
(100 %id)
BI333691 cervical carcinoma cell line, cervix .a 169 to 943 1 to 768       768/860
(89 %)
17 diff
(98.1 %id)
CN311679 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 170 to 920 1 to 750       750/750
(100 %)
8 diff
(99.0 %id)
BE206783 lung, small cell carcinoma .a 170 to 699 1 to 530       530/530
(100 %)
5 diff
(99.1 %id)
BE900889 choriocarcinoma, placenta .a 170 to 934 1 to 760       760/1014
(74 %)
15 diff
(98.6 %id)
BI829224 brain, medulla .a 170 to 945 1 to 773       773/773
(100 %)
6 diff
(99.3 %id)
BQ229885 melanotic melanoma, skin .a 170 to 900 1 to 736       736/923
(79 %)
12 diff
(98.7 %id)
CA489719   .a 170 to 948 1 to 782       782/903
(86 %)
19 diff
(97.9 %id)
BE796945 lung, small cell carcinoma .a 174 to 941 1 to 769       769/1029
(74 %)
12 diff
(98.9 %id)
BU177930 melanotic melanoma, skin .a 176 to 935 1 to 771       771/892
(86 %)
17 diff
(98.1 %id)
BE208592 lung, small cell carcinoma .a 177 to 586 1 to 410       410/410
(100 %)
2 diff
(99.6 %id)
BG331834 large cell carcinoma, lung .a 178 to 927 1 to 752       752/1105
(68 %)
20 diff
(98.2 %id)
AW250341 lung, small cell carcinoma .a 179 to 716 9 to 546       538/546
(98 %)
2 diff
(99.7 %id)
BI761244 pooled colon, kidney, stomach .a 179 to 935 1 to 759       759/759
(100 %)
7 diff
(99.1 %id)
CR625055 Neuroblastoma Cot 25-normalized .a 181 to 1779 1 to 1599       1599/1599
(100 %)
0 diff
(100 %id)
BX376478 Neuroblastoma Cot 25-normalized .a 181 to 1004 1 to 825   fully sequenced,   825/825
(100 %)
8 diff
(99.1 %id)
BU521320 leiomyosarcoma, uterus .a 181 to 949 1 to 771       771/892
(86 %)
14 diff
(98.5 %id)
BX366979   .a 183 to 969 26 to 811   fully sequenced,   786/811
(96 %)
8 diff
(99.1 %id)
BX362798   .a 183 to 997 26 to 840   fully sequenced,   815/840
(97 %)
9 diff
(99.0 %id)
BG682041 skin, squamous cell carcinoma .a 183 to 910 1 to 728       728/730
(99 %)
8 diff
(99.0 %id)
CR594244 Placenta Cot 25-normalized .a 184 to 1785 1 to 1602       1602/1602
(100 %)
0 diff
(100 %id)
CR607681 HeLa cells Cot 25-normalized .a 184 to 1795 1 to 1612       1612/1612
(100 %)
0 diff
(100 %id)
BE780271 eye, retinoblastoma .a 184 to 939 1 to 756       756/866
(87 %)
20 diff
(97.7 %id)
BG338536 leiomyosarcoma cell line, uterus .a 184 to 939 1 to 754       713/985
(72 %)
24 diff
(97.6 %id)
BE797002 lung, small cell carcinoma .a 185 to 939 1 to 750       750/936
(80 %)
13 diff
(98.7 %id)
BE299978 muscle, rhabdomyosarcoma .a 186 to 948 1 to 762       762/970
(78 %)
15 diff
(98.5 %id)
BI821773 pooled brain, lung, testis .a 187 to 1009 1 to 818       818/818
(100 %)
21 diff
(97.5 %id)
BE796904 lung, small cell carcinoma .a 188 to 939 1 to 750       750/971
(77 %)
7 diff
(99.3 %id)
BG490746 large cell carcinoma, lung .a 188 to 935 1 to 743       743/743
(100 %)
16 diff
(97.9 %id)
BQ069980 brain, neuroblastoma, cell line .a 188 to 955 1 to 770       770/1055
(72 %)
17 diff
(98.4 %id)
BQ672053 epidermoid carcinoma, cell line, salivary gland .a 188 to 927 1 to 748       748/997
(75 %)
28 diff
(97.2 %id)
BE208470 lung, small cell carcinoma .a 190 to 728 1 to 539       539/539
(100 %)
2 diff
(99.7 %id)
BM810408 astrocytoma grade IV, cell line, brain .a 191 to 938 1 to 749       749/1028
(72 %)
18 diff
(98.3 %id)
BU196049 melanotic melanoma, cell line, skin .a 191 to 900 1 to 717       717/901
(79 %)
14 diff
(98.5 %id)
BQ671922 epidermoid carcinoma, cell line, salivary gland .a 191 to 943 1 to 757       757/876
(86 %)
12 diff
(98.7 %id)
BQ674844 epidermoid carcinoma, cell line, salivary gland .a 191 to 927 1 to 741       741/911
(81 %)
15 diff
(98.4 %id)
BQ672304 epidermoid carcinoma, cell line, salivary gland .a 191 to 955 1 to 767       767/969
(79 %)
26 diff
(97.4 %id)
BQ675184 epidermoid carcinoma, cell line, salivary gland .a 191 to 944 1 to 757       757/954
(79 %)
16 diff
(98.4 %id)
CR605290 HeLa cells Cot 25-normalized .a 194 to 1758 1 to 1565       1565/1565
(100 %)
0 diff
(100 %id)
AL555205 placenta .a 194 to 899 1 to 706   fully sequenced,   706/706
(100 %)
2 diff
(99.8 %id)
BG697286 skin .a 195 to 1023 1 to 829       829/916
(90 %)
22 diff
(97.6 %id)
BG259604 embryonal carcinoma, cell line, testis .a 203 to 935 1 to 731       731/811
(90 %)
13 diff
(98.4 %id)
BQ669095 epidermoid carcinoma, cell line, salivary gland .a 204 to 1003 1 to 809       809/916
(88 %)
18 diff
(98.1 %id)
CF272397 Brain glioblastoma .a 204 to 994 1 to 797       795/922
(86 %)
18 diff
(98.1 %id)
BM800090 leiomyosarcoma, uterus .a 207 to 1067 1 to 870       870/1029
(84 %)
24 diff
(97.7 %id)
BQ944166 carcinoma, cell line, Prostate .a 207 to 944 1 to 739       739/959
(77 %)
8 diff
(99.2 %id)
BU541974 carcinoma, cell line, Prostate .a 207 to 980 1 to 780       780/916
(85 %)
11 diff
(98.8 %id)
BQ279099 adenocarcinoma, cell line, breast .a 208 to 1064 1 to 870       870/981
(88 %)
26 diff
(97.4 %id)
BU539502 adenocarcinoma, cell line, breast .a 208 to 939 1 to 736       736/959
(76 %)
11 diff
(98.9 %id)
BE560735 Burkitt lymphoma, lymph .a 209 to 1038 1 to 831       739/1073
(68 %)
19 diff
(98.3 %id)
BX401149   .a 211 to 968 29 to 786   fully sequenced,   758/786
(96 %)
7 diff
(99.2 %id)
CX787734 human embryonic stem cells .a 229 to 1017 1 to 789       789/789
(100 %)
4 diff
(99.5 %id)
BI913620 brain .a 353 to 1220 1 to 870       870/874
(99 %)
15 diff
(98.3 %id)
TI_57241377   .a 353 to 1273 37 to 953       917/1007
(91 %)
34 diff
(96.7 %id)
CA488468   .a 424 to 1339 1 to 915       915/1032
(88 %)
41 diff
(96.1 %id)
TI_59386227   .a 427 to 1271 66 to 909       844/910
(92 %)
11 diff
(98.8 %id)
BM008530 adenocarcinoma, Pancreas .a 452 to 1271 1 to 819       819/820
(99 %)
5 diff
(99.4 %id)
BE542882 cervix .a 460 to 1202 1 to 740       740/995
(74 %)
23 diff
(97.7 %id)
BQ954144 sciatic nerve .a 462 to 1329 1 to 873       873/882
(98 %)
21 diff
(97.7 %id)
BE797354 lung, small cell carcinoma .a 463 to 1274 1 to 803       803/970
(82 %)
24 diff
(97.6 %id)
TI_1948093880   .a 475 to 1105 129 to 759       631/1300
(48 %)
13 diff
(99.0 %id)
BG577067 breast, mammary adenocarcinoma, cell line .a 496 to 1209 1 to 715       715/715
(100 %)
3 diff
(99.6 %id)
BG502851 embryonal carcinoma, testis .a 521 to 1264 1 to 749       747/757
(98 %)
8 diff
(99.0 %id)
BG387050 adenocarcinoma cell line, colon .a 532 to 1273 1 to 738       738/835
(88 %)
8 diff
(99.1 %id)
BU157151 melanotic melanoma, cell line, skin .a 536 to 1262 1 to 730       730/893
(81 %)
17 diff
(98.1 %id)
BQ683578 melanotic melanoma, cell line, skin .a 536 to 1339 1 to 807       807/980
(82 %)
19 diff
(98.1 %id)
BQ682736 melanotic melanoma, cell line, skin .a 536 to 1420 1 to 889       889/919
(96 %)
20 diff
(97.9 %id)
BU902580 leiomyosarcoma, uterus .a 586 to 1458 1 to 874       874/877
(99 %)
19 diff
(97.9 %id)
BU956413 adenocarcinoma, cell line, breast .a 598 to 1432 1 to 842       842/886
(95 %)
11 diff
(98.8 %id)
CD635305   .a 602 to 1314 724 to 12       713/724
(98 %)
3 diff
(99.6 %id)
CA488745   .a 615 to 1432 1 to 818       818/904
(90 %)
25 diff
(97.3 %id)
BQ230795 epithelioid carcinoma, Pancreas .a 638 to 1458 1 to 827       827/856
(96 %)
12 diff
(98.6 %id)
CD672153 eye, Iris .a 639 to 1155 1 to 517       517/517
(100 %)
2 diff
(99.7 %id)
BM459261 lymph, lymphoma, cell line .a 739 to 1497 6 to 769       764/986
(77 %)
14 diff
(98.6 %id)
BI115813 lung, small cell carcinoma .a 740 to 1633 1 to 895       893/970
(92 %)
44 diff
(95.5 %id)
BX333722 Neuroblastoma Cot 25-normalized .a 749 to 1796 1035 to 1       1035/1058
(97 %)
32 diff
(97.0 %id)
BG479271 choriocarcinoma, placenta .a 753 to 1497 1 to 745       745/745
(100 %)
6 diff
(99.2 %id)
TI_59391525   .a 769 to 1605 88 to 928       841/846
(99 %)
11 diff
(98.7 %id)
BM013622 breast, mammary adenocarcinoma, cell line .a 770 to 1605 1 to 840       840/845
(99 %)
11 diff
(98.7 %id)
BE732575 choriocarcinoma, placenta .a 774 to 1498 1 to 727       727/868
(83 %)
10 diff
(98.9 %id)
BG830466 epithelioid carcinoma cell line, Pancreas .a 776 to 1582 1 to 810       810/811
(99 %)
13 diff
(98.4 %id)
BG760877 melanotic melanoma, high MDR (cell line), skin .a 834 to 1757 1 to 921       921/921
(100 %)
20 diff
(97.9 %id)
BE793772 lung, small cell carcinoma .a 840 to 1687 1 to 837       837/975
(85 %)
24 diff
(97.6 %id)
BU956322 adenocarcinoma, cell line, breast .a 851 to 1575 1 to 727       727/906
(80 %)
13 diff
(98.6 %id)
BX333426 Neuroblastoma Cot 25-normalized .a 852 to 1760 902 to 1       902/922
(97 %)
20 diff
(97.9 %id)
BX334663 Placenta Cot 25-normalized .a 852 to 1771 933 to 20       914/980
(93 %)
17 diff
(98.3 %id)
BQ644501 hepatocellular carcinoma, cell line, Liver .a 859 to 1639 1 to 791       791/947
(83 %)
30 diff
(96.9 %id)
BU500148   .a 860 to 1753 2 to 910       909/920
(98 %)
33 diff
(96.5 %id)
AL581469 B cells (Ramos cell line), B cells from Burkitt lymphoma .a 868 to 1777 935 to 31   fully sequenced,   905/935
(96 %)
8 diff
(99.2 %id)
BX363815   .a 868 to 1752 909 to 28   fully sequenced,   882/909
(97 %)
7 diff
(99.3 %id)
AL577759 placenta .a 869 to 1758 886 to 1   fully sequenced,   886/886
(100 %)
11 diff
(98.8 %id)
BX444138 fetal liver, Liver .a 869 to 1777 903 to 1   fully sequenced,   903/903
(100 %)
17 diff
(98.2 %id)
BM047076 carcinoma, cell line, Prostate .a 881 to 1610 1 to 730       730/731
(99 %)
9 diff
(98.8 %id)
BX351243 Neuroblastoma Cot 25-normalized .a 892 to 1822 935 to 1       935/935
(100 %)
33 diff
(96.5 %id)
BX401148   .a 907 to 1795 888 to 1   fully sequenced,   888/888
(100 %)
9 diff
(99.0 %id)
BX342700   .a 907 to 1785 876 to 1   fully sequenced,   876/876
(100 %)
11 diff
(98.8 %id)
BX343134   .a 907 to 1779 871 to 5   fully sequenced,   867/871
(99 %)
7 diff
(99.2 %id)
BQ070796 brain, neuroblastoma, cell line .a 930 to 1818 1 to 903       903/1029
(87 %)
31 diff
(97.0 %id)
BX366978   .a 939 to 1776 840 to 1   fully sequenced,   840/840
(100 %)
13 diff
(98.5 %id)
AL520184 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 966 to 1766 823 to 26   fully sequenced,   798/823
(96 %)
7 diff
(99.2 %id)
BX362797   .a 967 to 1787 818 to 1   fully sequenced,   818/818
(100 %)
18 diff
(97.8 %id)
BX342295   .a 969 to 1804 831 to 1   fully sequenced,   831/831
(100 %)
9 diff
(99.0 %id)
BX355043 Neuroblastoma Cot 25-normalized .a 974 to 1779 803 to 1   fully sequenced,   803/803
(100 %)
21 diff
(97.4 %id)
BG387750 embryonal carcinoma, cell line, testis .a 978 to 1699 1 to 715       715/930
(76 %)
10 diff
(99.0 %id)
BF980007 testis .a 992 to 1776 780 to 1       780/826
(94 %)
17 diff
(98.0 %id)
BG283751 adenocarcinoma, cell line, Prostate .a 993 to 1702 1 to 712       712/716
(99 %)
9 diff
(98.8 %id)
BE300078 muscle, rhabdomyosarcoma .a 1022 to 1759 749 to 10       740/962
(76 %)
10 diff
(99.0 %id)
BG338983 leiomyosarcoma cell line, uterus .a 1034 to 1813 1 to 769       769/858
(89 %)
15 diff
(98.3 %id)
BQ182051 Knee, Osteoarthritic Cartilage .a 1044 to 1818 782 to 19   AAA   764/798
(95 %)
12 diff
(98.5 %id)
BQ216561 melanotic melanoma, skin .a 1102 to 1826 1 to 725       725/904
(80 %)
6 diff
(99.4 %id)
BX413269 brain, fetal brain .a 1106 to 1792 721 to 31       691/850
(81 %)
18 diff
(97.9 %id)
TI_1948093881   .a 1113 to 1734 736 to 112       625/1248
(50 %)
17 diff
(98.7 %id)
CB242835 Human Lung Epithelial cells, lung .a 1160 to 1818 676 to 19   AAA   658/658
(100 %)
1 diff
(99.9 %id)
BX097489 ovarian tumor, ovary .a 1164 to 1820 1 to 657   AAA   657/657
(100 %)
0 diff
(100 %id)
CD513122 brain, Pituitary .a 1168 to 1818 1 to 651   AAA   651/651
(100 %)
0 diff
(100 %id)
BE170910 head_neck .a 1183 to 1367 189 to 4     Submitted on the opposite strand 186/189
(98 %)
4 diff
(97.9 %id)
CA432295 cell lines, Enchondroma .a 1194 to 1818 643 to 19   AAA   625/626
(99 %)
0 diff
(100 %id)
ES310147 scalp interfollicular dermis, skin .a 1213 to 1818 613 to 20   AAA Submitted on the opposite strand 594/749
(79 %)
16 diff
(97.9 %id)
CD672152 eye, Iris .a 1259 to 1818 577 to 18   AAA   560/560
(100 %)
0 diff
(100 %id)
AW731948 lung, small cell carcinoma .a 1262 to 1830 572 to 4       569/572
(99 %)
2 diff
(99.7 %id)
BE881379 large cell carcinoma, undifferentiated, lung .a 1284 to 1815 1 to 532       532/532
(100 %)
0 diff
(100 %id)
AW731925 lung, small cell carcinoma .a 1287 to 1814 528 to 1       528/529
(99 %)
0 diff
(100 %id)
AI954975 four pooled poorly-differentiatedadenocarcinomas, lung .a 1302 to 1832 544 to 14   AAA   531/531
(100 %)
0 diff
(100 %id)
AW249989 lung, small cell carcinoma .a 1336 to 1818 493 to 11   AAA   483/483
(100 %)
0 diff
(100 %id)
BF816683 colon_ins .a 1337 to 1701 371 to 10     Submitted on the opposite strand 362/395
(91 %)
0 diff
(100 %id)
AI433652 lymph node, lymphoma, follicular mixed small and largecell .a 1343 to 1818 476 to 1       476/476
(100 %)
0 diff
(100 %id)
AW251076 lung, small cell carcinoma .a 1351 to 1818 478 to 11   AAA   468/468
(100 %)
1 diff
(99.8 %id)
AI275203 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1384 to 1818 453 to 19   AAA   435/435
(100 %)
0 diff
(100 %id)
BP395590 pancreatic islet .a 1391 to 1817 1 to 427     Submitted on the opposite strand 427/427
(100 %)
0 diff
(100 %id)
TI_57168064   .a 1391 to 1819 79 to 514   AAA   445/514
(86 %)
56 diff
(89.2 %id)
AI473608 colon, moderately-differentiated adenocarcinoma .a 1398 to 1819 422 to 1       422/422
(100 %)
0 diff
(100 %id)
DB525396 testis .a 1401 to 1824 1 to 424   AAA Submitted on the opposite strand 424/424
(100 %)
0 diff
(100 %id)
BE940550 uterus_tumor .a 1417 to 1784 371 to 4       368/371
(99 %)
1 diff
(99.8 %id)
AW803859 uterus .a 1424 to 1634 211 to 1       211/230
(91 %)
4 diff
(98.3 %id)
AW953901   .a 1479 to 1824 1 to 346   AAA   346/346
(100 %)
0 diff
(100 %id)
AW953902   .a 1479 to 1824 1 to 346   AAA   346/346
(100 %)
0 diff
(100 %id)
AW615526 lung, small cell carcinoma .a 1483 to 1818 339 to 4       336/339
(99 %)
0 diff
(100 %id)
AW002892 pooled germ cell tumors .a 1514 to 1818 305 to 1       305/305
(100 %)
0 diff
(100 %id)
BE673079 pooled germ cell tumors .a 1514 to 1818 305 to 1       305/305
(100 %)
0 diff
(100 %id)
AA626535 lung, lung carcinoma .a 1523 to 1818 304 to 8     Submitted on the opposite strand 297/316
(93 %)
0 diff
(100 %id)
AW194678 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 1523 to 1819 297 to 1       297/297
(100 %)
0 diff
(100 %id)
BM726075 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1555 to 1818 1 to 264   fully sequenced, AAA   264/264
(100 %)
0 diff
(100 %id)
AI522032 Kidney .a 1565 to 1818 254 to 1       254/254
(100 %)
0 diff
(100 %id)
AI784435 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1566 to 1820 255 to 1       255/255
(100 %)
0 diff
(100 %id)
AA043111 uterus .a 1568 to 1812 1 to 245   fully sequenced,   245/245
(100 %)
2 diff
(99.2 %id)
AI784427 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1571 to 1820 250 to 1       250/250
(100 %)
0 diff
(100 %id)
AA027965 uterus .a 1580 to 1721 1 to 142       142/142
(100 %)
0 diff
(100 %id)
AI611359 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1605 to 1818 231 to 18   AAA   214/214
(100 %)
0 diff
(100 %id)
BM682511 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1672 to 1818 165 to 19   fully sequenced, AAA   147/147
(100 %)
0 diff
(100 %id)
AA595541 lung, lung tumor .a 1686 to 1811 126 to 1       126/126
(100 %)
0 diff
(100 %id)
AA040863 uterus .a 1693 to 1819 151 to 26   fully sequenced, AAA   126/126
(100 %)
0 diff
(100 %id)
BM772111 stomach .a 1708 to 1818 1 to 111   AAA   111/111
(100 %)
0 diff
(100 %id)
TI_57236395   .b 1 to 673 37 to 709   tiling clone,   673/710
(94 %)
10 diff
(98.6 %id)
BI910995 leukocyte .b 2 to 673 1 to 672       672/673
(99 %)
6 diff
(99.2 %id)
BQ950179 epidermoid carcinoma, cell line, lung .b 29 to 560 1 to 534       534/1063
(50 %)
20 diff
(98.2 %id)
CR626799 Neuroblastoma Cot 10-normalized .b 33 to 1655 1 to 1623   tiling clone,   1623/1623
(100 %)
0 diff
(100 %id)
AL522491 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 33 to 758 1 to 726   fully sequenced,   726/726
(100 %)
8 diff
(98.9 %id)
AW246329 lung, small cell carcinoma .b 41 to 165 1 to 125       125/125
(100 %)
6 diff
(95.2 %id)
AW247574 lung, small cell carcinoma .b 49 to 181 10 to 142       133/142
(93 %)
6 diff
(95.8 %id)
BE266908 lung, small cell carcinoma .b 86 to 686 47 to 678       629/704
(89 %)
80 diff
(88.7 %id)
AL522490 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 728 to 1655 924 to 1   fully sequenced,   924/924
(100 %)
15 diff
(98.4 %id)
AW246542 lung, small cell carcinoma .b 1201 to 1673 483 to 11   AAA   473/473
(100 %)
8 diff
(98.4 %id)
AW245175 lung, small cell carcinoma .b 1234 to 1677 454 to 11   tiling clone, AAA   444/444
(100 %)
0 diff
(100 %id)
AA809531 normal prostatic epithelial cells, Prostate .b 1671 to 1858 17 to 204       188/204
(92 %)
0 diff
(100 %id)
AW498678 brain .b 1674 to 2054 1 to 381       381/381
(100 %)
0 diff
(100 %id)
AA838292 colon, colon tumor .b 1674 to 2090 1 to 417   tiling clone,   417/418
(99 %)
2 diff
(99.6 %id)
AW067997 Bone, Hip .b 1705 to 2080 8 to 383       376/383
(98 %)
6 diff
(98.5 %id)
AW385117 head_neck .b 1718 to 2069 1 to 352       352/352
(100 %)
3 diff
(99.2 %id)
BF844403 head_neck .b 1734 to 2105 1 to 377       377/377
(100 %)
12 diff
(96.9 %id)
BF928701 nervous_tumor .b 1738 to 2126 1 to 389   tiling clone,   389/389
(100 %)
5 diff
(98.8 %id)
BI002384 head_normal .b 1750 to 2042 1 to 291       291/291
(100 %)
7 diff
(97.6 %id)
BF844410 head_neck .b 1796 to 2105 1 to 315       315/315
(100 %)
24 diff
(92.4 %id)
BF844405 head_neck .b 1799 to 2105 1 to 311       311/311
(100 %)
18 diff
(94.3 %id)
BF844409 head_neck .b 1799 to 2105 1 to 313       313/313
(100 %)
13 diff
(95.9 %id)
FN052180 breast carcinoma .b 1805 to 1895 1 to 91       91/92
(98 %)
1 diff
(99.0 %id)
BQ359508 head_normal .b 1835 to 2031 1 to 203       203/213
(95 %)
7 diff
(96.8 %id)
BE937723 testis_normal .b 1866 to 2092 1 to 233       233/233
(100 %)
10 diff
(95.8 %id)
BX342750   .c 1 to 857 1 to 853   fully sequenced,   853/853
(100 %)
18 diff
(97.9 %id)
CR596639 B cells (Ramos cell line) Cot 25-normalized .c 2 to 1708 1 to 1707 exact tiling clone,   1707/1707
(100 %)
0 diff
(100 %id)
CR591297 fetal liver .c 158 to 1696 1 to 1539       1539/1539
(100 %)
0 diff
(100 %id)
BX448935 fetal liver, Liver .c 179 to 1053 21 to 895   fully sequenced,   875/895
(97 %)
12 diff
(98.7 %id)
CR621430 HeLa cells Cot 25-normalized .c 185 to 1707 1 to 1523       1523/1523
(100 %)
0 diff
(100 %id)
BX386677   .c 213 to 969 29 to 785   fully sequenced,   757/785
(96 %)
13 diff
(98.4 %id)
BG338212 leiomyosarcoma cell line, uterus .c 217 to 1022 1 to 802       802/842
(95 %)
32 diff
(96.2 %id)
BE792814 lung, small cell carcinoma .c 342 to 946 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
AA070980   .c 460 to 833 1 to 379       379/450
(84 %)
12 diff
(97.4 %id)
BQ431757 leiomyosarcoma, uterus .c 545 to 1346 4 to 808       805/875
(92 %)
12 diff
(98.7 %id)
Z44606 brain, total brain .c 670 to 950 19 to 299       283/299
(94 %)
6 diff
(98.0 %id)
BQ228437 large cell carcinoma, lung .c 706 to 1423 8 to 726       719/872
(82 %)
20 diff
(97.8 %id)
BX342749   .c 825 to 1704 877 to 4   fully sequenced,   874/877
(99 %)
7 diff
(99.3 %id)
BX386676   .c 908 to 1707 796 to 1   fully sequenced,   796/796
(100 %)
8 diff
(99.0 %id)
BX448934 fetal liver, Liver .c 992 to 1696 703 to 1   fully sequenced,   703/703
(100 %)
2 diff
(99.8 %id)
AA070890   .c 1300 to 1727 438 to 10       429/438
(97 %)
4 diff
(99.1 %id)
Z40476 brain, total brain .c 1466 to 1737 271 to 1   tiling clone,   271/271
(100 %)
1 diff
(99.7 %id)
AK302098 testis .d 1 to 889 1 to 889   tiling clone,   889/889
(100 %)
2 diff
(99.8 %id)
BI083807 epidermoid carcinoma, cell line, salivary gland .d 193 to 672 1 to 481       481/662
(72 %)
7 diff
(99.0 %id)
DA849239 placenta .d 584 to 1160 2 to 578   tiling clone, capped   577/578
(99 %)
3 diff
(99.5 %id)
BI770627 pooled lung and spleen .d 673 to 1511 1 to 848   tiling clone,   848/939
(90 %)
16 diff
(98.3 %id)
TI_57183535   .d 675 to 1482 31 to 843       813/967
(84 %)
18 diff
(98.2 %id)
BI084475 epidermoid carcinoma, cell line, salivary gland .d 1145 to 1914 773 to 2   tiling clone,   772/773
(99 %)
12 diff
(98.5 %id)
TI_57161993   .e 1 to 659 31 to 688   tiling clone,   658/688
(95 %)
7 diff
(99.0 %id)
BI832640 pooled pancreas and spleen .e 5 to 659 1 to 654   tiling clone,   654/654
(100 %)
3 diff
(99.6 %id)
BM728744 eye, fetal eye .e 23 to 716 1 to 690   tiling clone,   690/690
(100 %)
6 diff
(99.2 %id)
BM705628 eye, lens .e 178 to 464 1 to 287       287/287
(100 %)
3 diff
(99.0 %id)
BU742662 eye, fetal eye .e 841 to 1349 526 to 19   tiling clone, AAA   510/508
(100 %)
4 diff
(99.3 %id)
BI919181 brain .f 1 to 791 33 to 824   tiling clone,   792/824
(96 %)
18 diff
(97.9 %id)
TI_57240252   .f 1 to 791 33 to 824       792/824
(96 %)
18 diff
(97.9 %id)
BQ067662 pooled brain, lung, testis .f 7 to 755 1 to 755   tiling clone,   755/1048
(72 %)
27 diff
(97.5 %id)
BG115752 duodenal adenocarcinoma, cell line, small intestine .f 41 to 769 1 to 709       711/846
(84 %)
30 diff
(96.5 %id)
DC397564 testis .f 209 to 767 1 to 560   tiling clone,   560/560
(100 %)
2 diff
(99.7 %id)
BG488766 large cell carcinoma, lung .f 761 to 1620 1 to 898   tiling clone,   896/900
(99 %)
51 diff
(94.4 %id)
BQ890090 brain, neuroblastoma, cell line .g 1 to 793 16 to 817   tiling clone,   802/891
(90 %)
24 diff
(97.4 %id)
AW248348 lung, small cell carcinoma .g 6 to 73 1 to 68       68/68
(100 %)
4 diff
(94.2 %id)
BG683355 brain, neuroblastoma, cell line .g 9 to 747 1 to 740   tiling clone,   740/740
(100 %)
12 diff
(98.4 %id)
BQ069195 brain, neuroblastoma, cell line .g 12 to 673 1 to 664       664/1143
(58 %)
10 diff
(99.2 %id)
BE796622 lung, small cell carcinoma .g 46 to 878 1 to 831   tiling clone,   831/875
(94 %)
27 diff
(97.0 %id)
BG683967 brain, neuroblastoma, cell line .g 758 to 1499 781 to 1   tiling clone,   781/855
(91 %)
56 diff
(93.5 %id)
AW247922 lung, small cell carcinoma .g 1173 to 1547 388 to 11   tiling clone, AAA   378/380
(99 %)
6 diff
(98.5 %id)
BX341516   .h 1 to 950 2 to 951 S2I W47A E48G T49D K50E ... tiling clone,   950/951
(99 %)
16 diff
(98.4 %id)
BG177634 lymph, lymphoma, cell line .h 5 to 744 12 to 742   tiling clone,   731/742
(98 %)
21 diff
(97.2 %id)
BG337677 leiomyosarcoma cell line, uterus .h 44 to 810 1 to 753       753/855
(88 %)
25 diff
(97.1 %id)
BE733112 choriocarcinoma, placenta .h 63 to 789 1 to 726       728/726
(100 %)
16 diff
(97.8 %id)
BE731352 choriocarcinoma, placenta .h 64 to 816 1 to 748   tiling clone,   748/749
(99 %)
13 diff
(98.3 %id)
BE312858 brain, neuroblastoma .h 182 to 953 1 to 769       769/1111
(69 %)
18 diff
(98.4 %id)
CD515784 White Matter .h 286 to 1214 1 to 933       933/985
(94 %)
24 diff
(97.6 %id)
BM011951 brain, neuroblastoma, cell line .h 321 to 1221 1 to 906   tiling clone,   906/910
(99 %)
23 diff
(97.5 %id)
TI_59381137   .h 322 to 1221 99 to 1003       905/909
(99 %)
22 diff
(97.6 %id)
BQ648998 hepatocellular carcinoma, cell line, Liver .h 404 to 1307 13 to 928   tiling clone,   916/994
(92 %)
23 diff
(97.7 %id)
BQ652967 hepatocellular carcinoma, cell line, Liver .h 405 to 1224 1 to 821   tiling clone,   821/929
(88 %)
8 diff
(99.2 %id)
BI758511 brain .i 1 to 741 22 to 761   tiling clone,   740/766
(96 %)
13 diff
(98.4 %id)
TI_57218364   .i 1 to 741 22 to 761       740/766
(96 %)
13 diff
(98.4 %id)
TI_45235917   .i 707 to 1234 57 to 584   tiling clone,   528/584
(90 %)
6 diff
(99.0 %id)
BI517545 pooled colon, kidney, stomach .i 714 to 1234 1 to 521   tiling clone,   521/521
(100 %)
3 diff
(99.5 %id)
DA564064 heart .i 816 to 1375 2 to 561   tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
CB126805 cervix, Uterine .i 1357 to 1965 1 to 610   tiling clone,   610/610
(100 %)
2 diff
(99.7 %id)
BI518096 pooled colon, kidney, stomach .i 1617 to 2376 816 to 7       698/1232
(56 %)
48 diff
(96.2 %id)
TI_45235918   .i 1617 to 2376 816 to 7   tiling clone,   698/1232
(56 %)
48 diff
(96.2 %id)
BG686320 B-cells, primary B-cells from tonsils (cell line) .j 1 to 649 1 to 647   tiling clone,   647/654
(98 %)
5 diff
(99.3 %id)
BF802455 colon_ins .j 130 to 439 1 to 310       310/310
(100 %)
7 diff
(97.8 %id)
CN311686 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 148 to 567 1 to 419       419/419
(100 %)
3 diff
(99.3 %id)
AA355301   .j 161 to 460 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
BF907058 uterus_tumor .j 176 to 518 11 to 353       343/355
(96 %)
12 diff
(96.7 %id)
CN311678 embryonic stem cells, cell lines H1, H7, andH9 .j 192 to 549 1 to 358       358/358
(100 %)
2 diff
(99.5 %id)
AW839384 leiomios .j 265 to 517 1 to 253       253/264
(95 %)
8 diff
(97.0 %id)
AW839387 leiomios .j 277 to 528 250 to 1       250/250
(100 %)
4 diff
(98.4 %id)
AA329499   .j 328 to 496 1 to 169       169/169
(100 %)
0 diff
(100 %id)
BM906707 ovary (pool of 3) .j 328 to 1067 1 to 742   tiling clone,   742/1166
(63 %)
13 diff
(98.9 %id)
BQ680864 melanotic melanoma, cell line, skin .j 331 to 635 1 to 305       305/305
(100 %)
1 diff
(99.7 %id)
BF738306 bladder_tumor .j 336 to 588 252 to 7     Submitted on the opposite strand 246/252
(97 %)
11 diff
(95.7 %id)
AA380717   .j 400 to 548 1 to 149       149/149
(100 %)
2 diff
(98.7 %id)
TI_149312135   .j 1029 to 1953 992 to 88   tiling clone, AAA   905/969
(93 %)
26 diff
(97.4 %id)
BM977836 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 1210 to 1953 761 to 19   tiling clone, AAA   743/743
(100 %)
1 diff
(99.9 %id)
AI521356 adenocarcinoma, Pancreas .j 1529 to 1955 429 to 3   tiling clone,   427/429
(99 %)
0 diff
(100 %id)
DA385882 thalamus .k-u 1 to 589 2 to 590 exact tiling clone, capped   589/589
(100 %)
2 diff
(99.7 %id)
AW450386   .l 1 to 409 426 to 18 exact AAA   409/419
(97 %)
0 diff
(100 %id)
CB050500 Prostate .l 1 to 409 10 to 418 exact tiling clone, fully sequenced, AAA   409/418
(97 %)
6 diff
(98.6 %id)
BX107069 Prostate .l 4 to 387 1 to 384       384/384
(100 %)
0 diff
(100 %id)
AI686477 Prostate .l 34 to 410 377 to 1       377/377
(100 %)
2 diff
(99.5 %id)
AI745399 Prostate .l 34 to 410 384 to 8       377/384
(98 %)
0 diff
(100 %id)
BG204038   .l 79 to 394 334 to 19     Submitted on the opposite strand 316/334
(94 %)
0 diff
(100 %id)
BG219571   .l 79 to 400 1 to 323       323/325
(99 %)
5 diff
(98.5 %id)
AI420742 Prostate .l 107 to 412 333 to 28   AAA   306/306
(100 %)
6 diff
(98.1 %id)
AI972431 Prostate .l 107 to 412 333 to 27   AAA   307/307
(100 %)
9 diff
(97.1 %id)
AI347432 colon, colon tumor, RER+ .l 158 to 408 254 to 3       252/254
(99 %)
0 diff
(100 %id)
CB050499 Prostate .l 174 to 409 261 to 26   fully sequenced, AAA   236/236
(100 %)
0 diff
(100 %id)
BF336652 colon .m-u 1 to 216 1 to 212 E4R N8S R9S E11D Q12K ... tiling clone,   212/225
(94 %)
10 diff
(95.6 %id)
480 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C